Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03026777 · ClinicalTrials.gov registry record · Phase 4

Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation

A Phase 4 study, sponsored by Louisiana State University Health Sciences Center in New Orleans.

Completed
Registry status
Phase 4
Development phase
337
Enrollment target

NCT03026777 is a Phase 4 study that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 337 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03026777, a Phase 4 study, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.

COMPLETED
Registry status
Phase 4
Development phase
337 participants
Enrollment target

Study Summary

Endotracheal intubation is common in the care of critically ill patients. Complications of airway management in this setting are frequently encountered and may be associated with an increased risk of death. The prevention of complications during urgent and emergent endotracheal intubation is a key focus for airway management research. Post-intubation hypotension (PIH), a common complication of endotracheal intubation in the critically ill, may be prevented by a bolus of intravenous fluid prior to the start of the procedure, but this approach has not been examined in a prospective trial. There are no randomized trials of intravenous fluid administration to prevent PIH in critically ill adults. The investigators propose a randomized trial of fluid loading to prevent PIH in critically ill adults.

Interventions

  • DRUG intravenous crystalloid fluid, 500 mL

Trial Details

FieldValue
Enrollment Target 337 participants
Start Date 2017-01
Est. Completion 2018-01
Phase Phase 4

What the Registry Record Tells You About NCT03026777

The ClinicalTrials.gov registry entry for NCT03026777 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 337 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which intravenous crystalloid fluid, 500 mL is the first listed.

NCT03026777 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03026777 about?

NCT03026777 is a clinical study titled "Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation". Endotracheal intubation is common in the care of critically ill patients. Complications of airway management in this setting are frequently encountered and may be associated with an increased risk of death. The prevention of complications during urgent and emergent endotracheal intubation is a key f...

What is the current status of trial NCT03026777?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 337 participants. The study started on 2017-01. Estimated completion is 2018-01.

What interventions are being tested in trial NCT03026777?

The interventions under investigation include: intravenous crystalloid fluid, 500 mL (DRUG).

Who is sponsoring clinical trial NCT03026777?

This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.